➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Colorcon
McKinsey
Mallinckrodt
Baxter

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Litigation Details for Andrulis Pharmaceuticals Corp. v. Celgene Corp. (D. Del. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Andrulis Pharmaceuticals Corp. v. Celgene Corp. (D. Del. 2013)

Docket   Start Trial Date Filed 2013-10-02
Court District Court, D. Delaware Date Terminated 2015-07-28
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand Plaintiff Referred To
Parties ANDRULIS PHARMACEUTICALS CORP.; CELGENE CORP.
Patents 7,230,012; 7,393,862; 7,465,800; 7,468,363; 7,723,361; 7,855,217; 7,893,045; 7,968,569; 8,188,118; 8,198,262; 8,410,136; 8,440,194
Attorneys Alexander E. Gasser; Derek James Fahnestock; Eliot J. Walker; Gasper J. LaRosa; John C. Evans; Kenneth Laurence Dorsney; Kenneth S. Canfield; Mary B. Graham; Paul J. Skiermont; Sarah E. Spires; Shellie Stephens; Stephen J. Kraftschik; Steven J. Udick; Toni-Ann Citera
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Andrulis Pharmaceuticals Corp. v. Celgene Corp.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Andrulis Pharmaceuticals Corp. v. Celgene Corp.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Andrulis Pharmaceuticals Corp. v. Celgene Corp. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-10-02 1 the 22 Celgene-owned patents identified above, such as U.S. Patent Nos. 7,230,012 and 7,723,361, which…the 22 Celgene-owned patents identified above, such as U.S. Patent Nos. 7,230,012 and 7,723,361, which… 7,230,012 7,323,479 … The Patent in Suit 9. U.S. Patent No. 6,140,346 (“the ’346 patent”), entitled “… 1. This action alleges patent infringement under the patent laws of the United States, Title External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Dow
Johnson and Johnson
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.